LongeVC managing partner Aurora Griffin will speak at this year's Longevity Biotech event, "Accelerating the Development of Longevity Therapeutics," in Boston on October 22-23.
The two-day gathering brings together 150+ leaders from biotech, pharma, academia, and venture capital to address the field's most pressing challenges: regulatory uncertainty, lack of validated biomarkers, complex clinical trial design, and the gap between scientific promise and clinical evidence.
With over 30 expert speakers covering the full spectrum of anti-aging drug development, the forum provides a focused platform for translational researchers, founders, and investors to exchange insights and establish pathways from discovery to application.
More information and registration here.
The two-day gathering brings together 150+ leaders from biotech, pharma, academia, and venture capital to address the field's most pressing challenges: regulatory uncertainty, lack of validated biomarkers, complex clinical trial design, and the gap between scientific promise and clinical evidence.
With over 30 expert speakers covering the full spectrum of anti-aging drug development, the forum provides a focused platform for translational researchers, founders, and investors to exchange insights and establish pathways from discovery to application.
More information and registration here.